IMC-Chicago, LLC

Position in BMRN — Biomarin Pharmaceutical Inc

CIK 1452861 CHICAGO, IL

Back to BMRN Full portfolio

Position in BMRN

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$541,701

+$225,357 QoQ

Shares Held

9,467

+69.1% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#333

of 561 holders

Holding Since

Mar 2021

6 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in BMRN Over Time

Shares Held

Position Value (USD)

Derivatives in BMRN

reported options exposure · as of Sep 30, 2021

CallValue

$3,362,115

CallShares

43,500

PutValue

$3,539,882

PutShares

45,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

IMC-Chicago, LLC holds $54,107,382 across 30 Biotechnology names. BMRN ranks #17 (1.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	87,392	$11,645,857
2	INSM	INSMED Inc	76,126	$8,116,554
3	MDGL	Madrigal Pharmaceuticals, Inc.	10,847	$5,824,296
4	CELC	Celcuity Inc.	41,127	$4,302,706
5	REGN	Regeneron Pharmaceuticals, Inc.	5,591	$3,486,212
6	BNTX	BioNTech SE	29,282	$2,724,690
7	AXSM	Axsome Therapeutics, Inc.	10,187	$2,493,471
8	ROIV	Roivant Sciences Ltd.	68,630	$2,428,815

All Filings in BMRN

Export CSV

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$541,701	9,467	+69.1%	Shares	Sole	2026-08-06
2026-03-31	$316,344	5,600	-52.8%	Shares	Sole	2026-05-05
2025-06-30	$652,274	11,866	-32.5%	Shares	Sole	2025-07-22
2021-12-31	$1,552,839	17,576	-27.1%	Shares	Sole	2022-02-08
2021-09-30	$3,539,882	45,800	—	Put	Sole	2021-11-05
2021-09-30	$3,362,115	43,500	—	Call	Sole	2021-11-05
2021-03-31	$1,821,376	24,121	—	Shares	Sole	2021-05-14
No filing history on record for this holder in this stock.